The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease
- 1 January 2005
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 94 (08) , 438-443
- https://doi.org/10.1160/th05-01-0046
Abstract
Schattauer GmbH - Verlag für Medizin und Naturwissenschaften ist ein renommierter Herausgeber von Fachbüchern, -zeitschriften und -software. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren ZeitschriftenartikelnKeywords
Funding Information
- Danish Heart Foundation (04-4-3-B50-A49-22167)
This publication has 32 references indexed in Scilit:
- Existence of a Clinically Relevant Interaction between Clopidogrel and HMG-CoA Reductase Inhibitors? Re-evaluating the EvidenceBasic & Clinical Pharmacology & Toxicology, 2005
- Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndromeHeart, 2005
- Atorvastatin Does Not Affect the Antiplatelet Potency of Clopidogrel When It Is Administered Concomitantly for 5 Weeks in Patients With Acute Coronary SyndromesCirculation, 2004
- Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel ResistanceCirculation, 2004
- New nonlipid effects of statins and their clinical relevance in cardiovascular diseaseThrombosis and Haemostasis, 2004
- ADP induced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatinThrombosis and Haemostasis, 2004
- Early and Late Effects of Clopidogrel in Patients With Acute Coronary SyndromesCirculation, 2003
- Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 2002
- Shorter PFA‐100® closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factorActa Paediatrica, 2001
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996